ABT soars on Friday night’s announcement of a point-of-care COVID-19 test (#msg-154626369), which was cited in Trump’s press briefing yesterday.
ABT won’t garner sales and profits from COVID-19 testing anywhere near commensurate with today’s increase in market cap, but this episode will certainly enhance ABT’s corporate reputation.